Press Releases

WCG Unveils 2025 Site Challenges Report to Fuel Clinical Research Transformation

WCG announced the release of the 2025 Site Challenges Report, offering exclusive insights into the evolving landscape of clinical trial sites worldwide.

Quotient Sciences and Biorasi partner to accelerate early phase clinical trials to patient proof-of-concept

Alithea Genomics Introduces MERCURIUS™ Spheroid DRUG-seq: Extraction-Free, RNA-seq for 3D Drug Screening and Toxicology

Alithea Genomics has announced the commercial launch of MERCURIUS™ Spheroid DRUG-seq, a novel, extraction-free RNA sequencing library preparation kit built for 3D spheroid models.

Association for Molecular Pathology Develops Standardized Biomarker Report Template for Providers

AMP announced the publication of a new simplified, consensus-driven NGS molecular biomarker report designed to support oncologists and other healthcare providers. This report provides clear, practical recommendations to help laboratories present complex molecular profiling data in a format that is both clinically useful and consistent with current guidelines.

Gifthealth is First to Serve 6m Patients Via Direct-to-Patient Platform

Gifthealth, the patient access solution that unifies the prescription journey from provider to patient, today announced it has now served more than six million patients through its direct-to-patient (DTP) platform.

CluePoints’ AI Breakthroughs Earn Dual Recognition at SCDM and SCRIP Awards

CluePoints, provider of leading statistical and AI-driven software solutions, has achieved dual recognition, winning the Clinical Data Science Implementation Excellence Award at the 2025 SCDM Annual Conference and has been named a finalist in the ‘Best Contract Research Organization– Specialist Providers’ category at the 2025 SCRIP Awards.

Lonza Expands its TheraPEAK® Product Portfolio with the Addition of AmpliCell® Cytokine Range and TheraPEAK® 293-GT® Medium

Lonza has announced the launch of TheraPEAK® AmpliCell® Cytokines and TheraPEAK® 293-GT® Medium to expand its GMP solutions for cell and gene therapy.

Phastar Scoops Multiple Finalist Positions in 2025 SCRIP Awards

Phastar, a global specialist biometrics & data science Contract Research Organization (CRO), has been named as finalists in two categories at the prestigious 2025 SCRIP Awards.

Industry Veterans Establish Ripston, Specialized Clinical Trial Marketing Agency

Ripston helps B2B clinical trial startups build strategic foundations, achieve product-market fit, balance authenticity with AI adoption, and expand to new markets.

Advarra’s site-sponsor consortium publishes industry report and master mutual CDA template to streamline feasibility and reduce study startup timelines

Advarra, the market leader in regulatory reviews and a leading provider of clinical research technology, today announced the Site-Sponsor Consortium’s first industry deliverable designed to streamline a common bottleneck in clinical trials: the Confidential Disclosure Agreement (CDA).

Quantabio Advances Newborn Screening and Emerging Applications by Streamlining DNA Extraction from Dried Blood Spot Samples

Quantabio launched the sparQ Lysis Kit, a flexible solution that delivers high-quality, double-stranded genomic DNA from DBS punches in under 50 minutes.

OptymEdge hires Senior Director to Drive Global Roll-Out of ACUVERA Platform

PromoCell enters the GMP field with custom cell culture media services for cell-based therapy and regenerative medicine

PromoCell GmbH has announced its entry into the Good Manufacturing Practice field.

Amorphical Announces Positive Interim Results from Ongoing Clinical Trial in Crohn’s Disease

Novel Nano-Amorphous Mineral-Based Therapy Shows Meaningful Clinical Improvement and Remission in Patients with Moderate-to-Severe Disease

Industry Research Finds Two-Thirds of Clinical Data Managers and CRAs Believe Current Inefficiencies Put Data Quality at Future Risk

Symbiosis Expands Sterile Manufacturing Capacity with Fill/Finish Line Qualification 

ClearNote Health Receives In Vitro Diagnostic Approval in United Kingdom for Avantect® Multi-Cancer Detection Test and Avantect® Ovarian Cancer Test

ClearNote Health Receives UKCA markings for Avantect® Multi-Cancer Detection Test and Avantect® Ovarian Cancer Test

Takara Bio Europe Launches Cellartis® MSC EV Wonder™, a Defined, Xeno-Free Medium for High-Yield EV Production

Takara Bio Europe announces the launch of Cellartis® MSC EV Wonder.

MIB Agents Now Accepting Letters of Intent for Annual OutSmarting Osteosarcoma Research Grants

Nonprofit Awards Grants to Projects Focused on Moving Research Forward for Rare Bone Cancer Patients

Certara Launches DIDB® Concomitant Meds Navigator, Extending Leadership in Drug Interaction Science

Certara on Sept. 22 launched a new capability in its Drug Interaction Database (DIDB) - the pharmaceutical industry’s largest scientist-curated collection of human in vitro and clinical data used to assess drug-drug interactions (DDIs) and safety - that allows researchers to rapidly identify medications that could impact a drug’s effects when taken together, allowing for safer and more intentional drug development.